Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Active against <i>Chlamydia </i>sp.,<i> Corynebacterium mediolanum, Mycobacterium bovis, Staphylococcus aureus, </i>and <i>Wolbachia</i> sp.

Reason dropped: Selects for resistance (7.2E-8) and has minimal activity, it was suggested this may be a potential scaffold for investigation and optimisation.

Additional information: Natural product from <i>Corallococcus </i>(=<i>Myxococcus</i>=<i>Chondrococcus</i>)<i> coralloides</i> strain Cc127 (DSM 2550)